Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting

Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting

Business Wire

Published

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #ASGCT--First look at preclinical data from DLVR-M, Nvelop's humanized particle platform for in vivo delivery of therapeutic cargoes.

Full Article